Foralumab Nasal
Tolerability, Safety
Phase I
Completed
Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers
Mar 11, 2025
―
Foralumab Nasal
Multiple System Atrophy
Phase II
Recruiting
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Mar 06, 2025
―
Foralumab Tzls-401 100 Μg
Non-Active Secondary Progressive Multiple Sclerosis
Phase II
Recruiting
Nasal Foralumab in Patients With Non-Active Secondary Progressive Multiple Sclerosis
Feb 12, 2025
―
Foralumab
Secondary Progressive Multiple Sclerosis
Phase II
Recruiting
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
Feb 02, 2024
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Tiziana Life Sciences Plc (0RP) have in its pipeline
0RP is currently developing the following drugs: Foralumab Nasal, Foralumab Nasal, Foralumab Tzls-401 100 Μg. These drug candidates are in various stages of clinical development as the company works toward FDA approval.